Exelixis, Inc. EXEL announced that the FDA has approved the label expansion of its lead drug Cabometyx (cabozantinib). The ...

Approval was based on findings from the pivotal CABINET trial showing improved PFS and response rates vs placebo.

Exelixis (EXEL) on Wednesday announced that the Food and Drug Administration has approved cabozantinib, or Cabometyx, for the treatment of ...

The FDA has approved Cabometyx for some patients 12 years old and older with pancreatic neuroendocrine tumors and extra-pancreatic neuroendocrine tumors.

Exelixis (EXEL) wins FDA approval for Cabometyx for advanced pancreatic and extra pancreatic neuroendocrine tumors in ...

Beta Bionics recently brought its iLet bionic pancreas to market in 2023 and completed an IPO to become a publicly-traded ...

The public has a right to know their risk when and if they choose to drink. Such labeling has precedents with that on tobacco ...

The study demonstrates that PAC-MANN-1 outperforms the widely used CA 19-9 biomarker, offering greater accuracy in detecting all stages of PDAC. The assay is particularly promising for identifying ...

Whether AI-generated content is properly labeled will be one of the criteria that internet application service providers must meet to gain approval before listing or launching their applications ...

Victims of a scandal which saw black children labelled "educationally subnormal" and wrongly sent to a school for mental and physical disabilities are calling for an inquiry. Labour MP for ...

Taiwan’s new president has formally labelled China a “foreign hostile force” and proposed a raft of new national security measures in the face of growing threats and a string of spying cases.

With the IDE submission targeted for 2025, the company aims to initiate clinical trials in the U.S. to support a labeling indication for the treatment of pancreatic cancer pain. The company’s ...